Dysphagia in Head and Neck Cancer With Radiation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNational Taiwan University Hospital

About this trial

This study focuses on swallowing dysfunction, a common issue affecting 60-75% of head and neck cancer patients due to tumor damage, treatment complications, and chemoradiotherapy side effects, which can lead to malnutrition and reduced quality of life. With limited research on the effects of radiation doses on swallowing muscles and nutrition, this study aims to evaluate these impacts in non-surgical patients undergoing radiotherapy, conducting assessments before treatment, three months after, and within one year post-treatment.

Eligibility criteria

Qualifiers

Patients scheduled to undergo radiotherapy or concurrent chemoradiotherapy ;

Aged between 18 and 80 years;

Able to perform self-care independently (ECOG ≤ 2);

All patients provide written informed consent.

Disqualifiers

Patients scheduled to undergo surgical treatment;

Patients with neuromuscular diseases, such as stroke or Parkinson's disease;

Patients with other diseases or complications, including heart disease classified as NYHA functional class ≥ 2 with thrombotic conditions, or lung disease classified as Hugh-Jones grade ≥ 4;

Patients with psychological disorders that may affect their ability to provide informed consent or comply with the study protocol;

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

50 Participants
are grouped into 1 trial group

Locations

This trial has no locations